Investor Relations
Contact & FAQs
Frequently Asked Questions
When was Spero Therapeutics Founded?
- Spero Therapeutics was founded in 2013 and went public on November 2, 2017.
On what Stock Exchange is Spero Therapeutics Traded and what is the ticker symbol?
- Spero Therapeutics is listed on the NASDAQ Global Market with a ticker symbol of SPRO.
Where is Spero Therapeutics corporate headquarters?
- Spero Therapeutics is headquartered in Cambridge, MA.
Who are the members of the Spero Therapeutics Board of Directors and Leadership Team?
- You can find information about the Board of Directors and Leadership Team on our website, here.
Does Spero Therapeutics pay a dividend? Do you have a Dividend Reinvestment Plan?
- We currently do not pay a dividend and do not offer a Dividend Reinvestment Plan.
What is Spero Therapeutics’ CUSIP?
- 84833T103.
How do I buy Spero Therapeutics stock?
- You will need to open a brokerage account.
How do I transfer stock, change the address of my shareholder account, or replace a lost stock certificate?
- Please contact your broker if you own your shares through a broker, or if you beneficially own your shares, please contact our transfer agent.
Who is Spero Therapeutics’ transfer agent?
- Computershare is Spero’s transfer agent.
Who is Spero Therapeutics’ independent auditor?
- Our independent auditor is PwC.
Where is Spero Therapeutics incorporated?
- Spero Therapeutics is incorporated in Delaware, United States.
How do I contact investor relations?
- You can reach out to investor relations at IR@sperotherapeutics.com.
How do I get added to Spero Therapeutics’ email list?
- To subscribe to Spero Therapeutics’ email list, sign up here.
Where can I find all the SEC filings for Spero Therapeutics? Where can I download and view quarterly and annual reports?
- All SEC filings can be found and downloaded here.